Editorial: The human microbiome: A new frontier in personalized cancer therapy
Front Cell Infect Microbiol
.
2022 Sep 14:12:1028120.
doi: 10.3389/fcimb.2022.1028120.
eCollection 2022.
Authors
Valeriy Poroyko
1
,
Edwin Ramos Manuel
2
,
Elena Ilina
3
Affiliations
1
Microbiology Department, LabCorp Drug Development, Indianapolis, IN, United States.
2
Beckman Research Institute, City of Hope, Duarte, CA, United States.
3
Laboratory of Molecular Genetics of Microorganisms, Federal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russia.
PMID:
36189340
PMCID:
PMC9516089
DOI:
10.3389/fcimb.2022.1028120
No abstract available
Keywords:
bioavailability; cancer; metaorganism; microbiome; personalized therapy.
Publication types
Editorial
MeSH terms
Gastrointestinal Microbiome*
Humans
Microbiota*
Neoplasms* / therapy